Health Care & Life Sciences » Biotechnology | Aratana Therapeutics Inc.

Aratana Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
123.00
767.00
678.00
38,551.00
25,573.00
35,412
Cost of Goods Sold (COGS) incl. D&A
488.00
2,296.00
1,993.00
3,624.00
18,558.00
11,165
Gross Income
365.00
1,529.00
1,315.00
34,927.00
7,015.00
24,247
SG&A Expense
17,823.00
36,721.00
46,031.00
57,804.00
44,023.00
35,635
EBIT
18,188.00
38,250.00
47,346.00
22,877.00
37,008.00
11,388
Unusual Expense
1,674.00
3,359.00
40,876.00
7,942.00
7,448.00
500
Non Operating Income/Expense
477.00
2,287.00
3,866.00
255.00
22.00
109
Interest Expense
432.00
1,060.00
1,585.00
3,396.00
3,481.00
3,391
Pretax Income
19,742.00
40,259.00
85,752.00
33,575.00
47,510.00
14,722
Income Tax
15,455.00
1,443.00
1,698.00
-
-
-
Consolidated Net Income
4,287.00
38,816.00
84,054.00
33,575.00
47,510.00
14,722
Net Income
4,287.00
38,816.00
84,054.00
33,575.00
47,510.00
14,722
Net Income After Extraordinaries
4,287.00
38,816.00
84,054.00
33,575.00
47,510.00
14,722
Net Income Available to Common
4,287.00
38,816.00
84,054.00
33,575.00
47,510.00
14,722
EPS (Basic)
0.39
1.30
2.45
0.95
1.17
0.32
Basic Shares Outstanding
11,059.40
29,767.40
34,355.50
35,273.20
40,494.30
46,606.90
EPS (Diluted)
0.39
1.30
2.45
0.95
1.17
0.32
Diluted Shares Outstanding
11,059.40
29,767.40
34,355.50
35,273.20
40,494.30
46,606.90
EBITDA
17,792.00
36,207.00
45,506.00
21,886.00
35,846.00
10,398
Non-Operating Interest Income
75.00
123.00
189.00
385.00
449.00
666

About Aratana Therapeutics

View Profile
Address
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
Employees -
Website http://www.aratana.com
Updated 07/08/2019
Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.